Catecholamine interference in enzymatic creatinine assays

Amy K. Saenger, Christina Lockwood, Christine L. Snozek, Thomas C. Milz, Brad S. Karon, Mitchell G. Scott, Allan S Jaffe

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

BACKGROUND: Enzymatic creatinine assays are routinely used in clinical laboratories to provide more accurate estimated glomerular filtration rates and to avoid a perceived lack of analytical specificity associated with picrate (Jaffe) methods. Negative interferences with the enzymatic creatinine assay, which we noted in several patients on dopamine or dobutamine, prompted our further investigation into interference of catecholamines with enzymatic methods. METHODS: Spiked solutions of dopamine, dobutamine, epinephrine, and norepinephrine were added to pooled sera at catecholamine concentrations consistent with clinically relevant dosing. Creatinine was measured enzymatically on the Roche P-Modular, Ortho Clinical Diagnostics Vitros 350, and Abbott i-STAT. Jaffe methods were performed on the Roche P-Modular and Siemens Dimension RxL. In 10 patients receiving dopamine and/or dobutamine via a venous or arterial line we evaluated and compared the extent of in vivo creatinine interference in paired serum samples obtained by venipuncture and from indwelling catheters. RESULTS: All catecholamines caused significant negative interference with the Roche enzymatic creatinine assay, most pronounced for dopamine and dobutamine. The Vitros enzymatic assay demonstrated slight negative interferences, and i-STAT enzymatic and Jaffe methods were unaffected by the presence of catecholamines. Significant (P < 0.001) differences in creatinine concentrations by Roche enzymatic vs Jaffe methods were observed in venipuncture specimens compared with arterial or venous catheter specimens, suggesting dopamine and dobutamine reversibly adhere to the catheter lumen. CONCLUSIONS: Negative interferences were pronounced for Roche enzymatic results in blood samples obtained from indwelling catheters, a phenomenon not observed in peripheral draws. Physicians and laboratorians should be alert to the possibility of a falsely low creatinine result and reevaluate questionable samples using a method unaffected by catecholamines.

Original languageEnglish (US)
Pages (from-to)1732-1736
Number of pages5
JournalClinical Chemistry
Volume55
Issue number9
DOIs
StatePublished - Sep 1 2009

Fingerprint

Enzyme Assays
Catecholamines
Dobutamine
Assays
Creatinine
Catheters
Dopamine
Indwelling Catheters
Phlebotomy
Clinical laboratories
Vascular Access Devices
Serum
Glomerular Filtration Rate
Epinephrine
Norepinephrine
Blood
Physicians

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Saenger, A. K., Lockwood, C., Snozek, C. L., Milz, T. C., Karon, B. S., Scott, M. G., & Jaffe, A. S. (2009). Catecholamine interference in enzymatic creatinine assays. Clinical Chemistry, 55(9), 1732-1736. https://doi.org/10.1373/clinchem.2009.127373

Catecholamine interference in enzymatic creatinine assays. / Saenger, Amy K.; Lockwood, Christina; Snozek, Christine L.; Milz, Thomas C.; Karon, Brad S.; Scott, Mitchell G.; Jaffe, Allan S.

In: Clinical Chemistry, Vol. 55, No. 9, 01.09.2009, p. 1732-1736.

Research output: Contribution to journalArticle

Saenger, AK, Lockwood, C, Snozek, CL, Milz, TC, Karon, BS, Scott, MG & Jaffe, AS 2009, 'Catecholamine interference in enzymatic creatinine assays', Clinical Chemistry, vol. 55, no. 9, pp. 1732-1736. https://doi.org/10.1373/clinchem.2009.127373
Saenger AK, Lockwood C, Snozek CL, Milz TC, Karon BS, Scott MG et al. Catecholamine interference in enzymatic creatinine assays. Clinical Chemistry. 2009 Sep 1;55(9):1732-1736. https://doi.org/10.1373/clinchem.2009.127373
Saenger, Amy K. ; Lockwood, Christina ; Snozek, Christine L. ; Milz, Thomas C. ; Karon, Brad S. ; Scott, Mitchell G. ; Jaffe, Allan S. / Catecholamine interference in enzymatic creatinine assays. In: Clinical Chemistry. 2009 ; Vol. 55, No. 9. pp. 1732-1736.
@article{bc033651fc5545d9aba310e69ee83cca,
title = "Catecholamine interference in enzymatic creatinine assays",
abstract = "BACKGROUND: Enzymatic creatinine assays are routinely used in clinical laboratories to provide more accurate estimated glomerular filtration rates and to avoid a perceived lack of analytical specificity associated with picrate (Jaffe) methods. Negative interferences with the enzymatic creatinine assay, which we noted in several patients on dopamine or dobutamine, prompted our further investigation into interference of catecholamines with enzymatic methods. METHODS: Spiked solutions of dopamine, dobutamine, epinephrine, and norepinephrine were added to pooled sera at catecholamine concentrations consistent with clinically relevant dosing. Creatinine was measured enzymatically on the Roche P-Modular, Ortho Clinical Diagnostics Vitros 350, and Abbott i-STAT. Jaffe methods were performed on the Roche P-Modular and Siemens Dimension RxL. In 10 patients receiving dopamine and/or dobutamine via a venous or arterial line we evaluated and compared the extent of in vivo creatinine interference in paired serum samples obtained by venipuncture and from indwelling catheters. RESULTS: All catecholamines caused significant negative interference with the Roche enzymatic creatinine assay, most pronounced for dopamine and dobutamine. The Vitros enzymatic assay demonstrated slight negative interferences, and i-STAT enzymatic and Jaffe methods were unaffected by the presence of catecholamines. Significant (P < 0.001) differences in creatinine concentrations by Roche enzymatic vs Jaffe methods were observed in venipuncture specimens compared with arterial or venous catheter specimens, suggesting dopamine and dobutamine reversibly adhere to the catheter lumen. CONCLUSIONS: Negative interferences were pronounced for Roche enzymatic results in blood samples obtained from indwelling catheters, a phenomenon not observed in peripheral draws. Physicians and laboratorians should be alert to the possibility of a falsely low creatinine result and reevaluate questionable samples using a method unaffected by catecholamines.",
author = "Saenger, {Amy K.} and Christina Lockwood and Snozek, {Christine L.} and Milz, {Thomas C.} and Karon, {Brad S.} and Scott, {Mitchell G.} and Jaffe, {Allan S}",
year = "2009",
month = "9",
day = "1",
doi = "10.1373/clinchem.2009.127373",
language = "English (US)",
volume = "55",
pages = "1732--1736",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "9",

}

TY - JOUR

T1 - Catecholamine interference in enzymatic creatinine assays

AU - Saenger, Amy K.

AU - Lockwood, Christina

AU - Snozek, Christine L.

AU - Milz, Thomas C.

AU - Karon, Brad S.

AU - Scott, Mitchell G.

AU - Jaffe, Allan S

PY - 2009/9/1

Y1 - 2009/9/1

N2 - BACKGROUND: Enzymatic creatinine assays are routinely used in clinical laboratories to provide more accurate estimated glomerular filtration rates and to avoid a perceived lack of analytical specificity associated with picrate (Jaffe) methods. Negative interferences with the enzymatic creatinine assay, which we noted in several patients on dopamine or dobutamine, prompted our further investigation into interference of catecholamines with enzymatic methods. METHODS: Spiked solutions of dopamine, dobutamine, epinephrine, and norepinephrine were added to pooled sera at catecholamine concentrations consistent with clinically relevant dosing. Creatinine was measured enzymatically on the Roche P-Modular, Ortho Clinical Diagnostics Vitros 350, and Abbott i-STAT. Jaffe methods were performed on the Roche P-Modular and Siemens Dimension RxL. In 10 patients receiving dopamine and/or dobutamine via a venous or arterial line we evaluated and compared the extent of in vivo creatinine interference in paired serum samples obtained by venipuncture and from indwelling catheters. RESULTS: All catecholamines caused significant negative interference with the Roche enzymatic creatinine assay, most pronounced for dopamine and dobutamine. The Vitros enzymatic assay demonstrated slight negative interferences, and i-STAT enzymatic and Jaffe methods were unaffected by the presence of catecholamines. Significant (P < 0.001) differences in creatinine concentrations by Roche enzymatic vs Jaffe methods were observed in venipuncture specimens compared with arterial or venous catheter specimens, suggesting dopamine and dobutamine reversibly adhere to the catheter lumen. CONCLUSIONS: Negative interferences were pronounced for Roche enzymatic results in blood samples obtained from indwelling catheters, a phenomenon not observed in peripheral draws. Physicians and laboratorians should be alert to the possibility of a falsely low creatinine result and reevaluate questionable samples using a method unaffected by catecholamines.

AB - BACKGROUND: Enzymatic creatinine assays are routinely used in clinical laboratories to provide more accurate estimated glomerular filtration rates and to avoid a perceived lack of analytical specificity associated with picrate (Jaffe) methods. Negative interferences with the enzymatic creatinine assay, which we noted in several patients on dopamine or dobutamine, prompted our further investigation into interference of catecholamines with enzymatic methods. METHODS: Spiked solutions of dopamine, dobutamine, epinephrine, and norepinephrine were added to pooled sera at catecholamine concentrations consistent with clinically relevant dosing. Creatinine was measured enzymatically on the Roche P-Modular, Ortho Clinical Diagnostics Vitros 350, and Abbott i-STAT. Jaffe methods were performed on the Roche P-Modular and Siemens Dimension RxL. In 10 patients receiving dopamine and/or dobutamine via a venous or arterial line we evaluated and compared the extent of in vivo creatinine interference in paired serum samples obtained by venipuncture and from indwelling catheters. RESULTS: All catecholamines caused significant negative interference with the Roche enzymatic creatinine assay, most pronounced for dopamine and dobutamine. The Vitros enzymatic assay demonstrated slight negative interferences, and i-STAT enzymatic and Jaffe methods were unaffected by the presence of catecholamines. Significant (P < 0.001) differences in creatinine concentrations by Roche enzymatic vs Jaffe methods were observed in venipuncture specimens compared with arterial or venous catheter specimens, suggesting dopamine and dobutamine reversibly adhere to the catheter lumen. CONCLUSIONS: Negative interferences were pronounced for Roche enzymatic results in blood samples obtained from indwelling catheters, a phenomenon not observed in peripheral draws. Physicians and laboratorians should be alert to the possibility of a falsely low creatinine result and reevaluate questionable samples using a method unaffected by catecholamines.

UR - http://www.scopus.com/inward/record.url?scp=69549088669&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69549088669&partnerID=8YFLogxK

U2 - 10.1373/clinchem.2009.127373

DO - 10.1373/clinchem.2009.127373

M3 - Article

VL - 55

SP - 1732

EP - 1736

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 9

ER -